Tarsier™ Pharma Announces two presentations at the International Ocular Inflammation Society (IOIS) 2021 Congress

Autor:	PR Newswire
Zdroj:	PR Newswire US. 12/02/2021.
Abstrakt:	TEL AVIV, Israel, Dec. 2, 2021 /PRNewswire/ --Tarsier Pharma, an advanced clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics for blinding ocular diseases, announced that the Company's recent activities will be shared in two presentations at the International Ocular Inflammation Society (IOIS) Congress (on Dec. 2-5, 2021): (1) results of GADOT 20/20 Phase I/II uveitis trial, (2) Tarsier Grading Image Scale for anterior chamber cell count. [ABSTRACT FROM PUBLISHER]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.